Related Experiment Videos
[Percutaneous coronary intervention in patients with diabetes mellitus]
Hanne Maare Søndergaard1, Hans Erik Bøtker, Morten Bøttcher
1Kardiologisk afdeling B, Skejby Sygehus, Arhus Universitetshospital, DK-8200 Arhus N. hanne.sondergaard@dadlnet.dk
Insights
Diabetics experience higher restenosis rates after percutaneous coronary intervention (PCI). Coronary artery bypass grafting (CABG) may offer better outcomes for diabetic patients with three-vessel disease, though more research is needed.
Area of Science:
- Cardiology
- Diabetology
- Vascular Surgery
Background:
- Diabetes mellitus significantly increases restenosis risk post-percutaneous coronary intervention (PCI).
- Stent use reduces restenosis but intimal hyperplasia remains a challenge in diabetic patients.
- Diabetics undergoing PCI face higher morbidity and mortality, potentially due to metabolic factors.
Purpose of the Study:
- To evaluate revascularization strategies for ischemic heart disease in diabetic patients.
- To compare outcomes of PCI versus coronary artery bypass grafting (CABG) in this population.
- To identify optimal treatment for diabetics with three-vessel disease.
Main Methods:
- Review of existing literature and retrospective subgroup analyses.
- Comparison of restenosis rates and clinical outcomes between diabetic and non-diabetic patients.
- Assessment of treatment effectiveness for percutaneous coronary intervention versus coronary artery bypass grafting.
Main Results:
- Diabetics exhibit increased restenosis and intimal hyperplasia after PCI, even with stents.
- Retrospective data suggest a more favorable outcome for diabetics treated with CABG.
- No randomized trials directly compare CABG and optimal PCI in diabetic populations.
Conclusions:
- Coronary artery bypass grafting (CABG) is presumed to be the optimal revascularization strategy for diabetic patients with three-vessel disease.
- Further randomized prospective studies are required to definitively clarify treatment guidelines for diabetics.
- Understanding diabetes-specific mechanisms of restenosis is crucial for improving PCI outcomes.
Abstract:
The incidence of restenosis after percutaneous coronary intervention (PCI) in patients with ischemic heart disease and diabetes is increased compared to non-diabetics. The use of stents has reduced the incidence of restenosis significantly but the effect is not convincing, as restenosis in diabetics predominantly consists of intimal hyperplasia. Even with the use of stents, diabetics have increased morbidity and mortality compared to non-diabetics. The precise mechanism is unknown but may include the metabolic abnormalities characteristic of diabetes. No randomised prospective studies in diabetics compare coronary artery by-pass grafting (CABG) with optimal angioplastic therapy. We await such studies to clarify the conditions for diabetics. Retrospective subgroup analyses indicate a more favourable outcome in diabetics revascularised by CABG. Thus CABG is presumably the optimal revascularisation treatment for diabetics with three-vessel disease.